Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection
NCT06021483 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-09-16
Summary
The purpose of this study is to evaluate the safety and efficacy of Zepzelca™ inj. in real-world practice and to investigate important identified risks and gaps in information related to risk management plans.
Conditions
Sponsors & Collaborators
-
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-16
- Primary Completion
- 2025-09-30
- Completion
- 2025-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
NCT07155174 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT02366143 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer
NCT02470468 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06954246 ·Status: RECRUITING ·Phase: PHASE3
-
Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
NCT06497530 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146 ·Status: RECRUITING ·Phase: PHASE3
-
Liver Directed RT + Chemo-immunotherapy for ES-SCLC
NCT04923776 ·Status: TERMINATED ·Phase: PHASE2
-
Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)
NCT00418743 ·Status: UNKNOWN
-
Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT00061854 ·Status: COMPLETED ·Phase: PHASE2
-
A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil
NCT06008353 ·Status: ACTIVE_NOT_RECRUITING
-
Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer
NCT01901653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy
NCT00063154 ·Status: COMPLETED ·Phase: PHASE2
-
Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)
NCT00198367 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer
NCT00046787 ·Status: COMPLETED ·Phase: PHASE2
-
Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
NCT06496048 ·Status: RECRUITING ·Phase: PHASE3
-
Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients
NCT01911325 ·Status: TERMINATED ·Phase: PHASE1
-
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
NCT02012231 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
NCT02927301 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
NCT04194944 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors
NCT04571632 ·Status: UNKNOWN ·Phase: PHASE2
-
BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC
NCT00410189 ·Status: COMPLETED ·Phase: PHASE2
-
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
NCT00062062 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
NCT01305967 ·Status: UNKNOWN ·Phase: PHASE2
-
Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
NCT06262321 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
NCT02409342 ·Status: COMPLETED ·Phase: PHASE3